| Dr Nadine L Teitelbaum, PHARMD | |
|
95 Newfield Ave, Edison, NJ 08837-3824 | |
| (732) 346-1333 | |
| (732) 346-1999 |
| Full Name | Dr Nadine L Teitelbaum |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 95 Newfield Ave, Edison, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013083658 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 2958600 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nadine L Teitelbaum, PHARMD 95 Newfield Ave, Edison, NJ 08837-3824 Ph: (732) 346-1333 | Dr Nadine L Teitelbaum, PHARMD 95 Newfield Ave, Edison, NJ 08837-3824 Ph: (732) 346-1333 |
News Archive
Writing in the Global Health Technologies Coalition's "Breakthroughs" blog, GHTC Policy Officer Ashley Bennett examines proposed funding for global health and research under President Obama's FY 2014 budget request, which was released last week.
Incyte Corporation (NASDAQ: INCY) announced today that it has entered into a collaboration and license agreement with Novartis for two of its investigational hematology-oncology therapies: INCB18424, an oral JAK1/JAK2 inhibitor that is in Phase III development for myelofibrosis, a serious life-threatening neoplastic condition characterized by varying degrees of bone marrow failure, splenic enlargement and debilitating constitutional symptoms, and INCB28060, an oral cMET inhibitor that is about to enter Phase I development as a potential treatment for multiple cancers.
A scientific study recently published on International Journal of Statistics in Medical Research states that tobacco consumption must be decreased by 15% in Spain, particularly at home, in order to reduce the number of childhood asthma cases.
Although kidney problems related to type 2 diabetes disproportionately affect blacks, when black and white individuals received comparable diabetes care within the context of a clinical trial, black race was not associated with faster development or progression of chronic kidney disease.
Scientists at the Princess Margaret Cancer Centre have discovered a function of the tumor suppressor gene PTEN that helps explain why certain promising therapies fail in many cancer patients, a finding that could aid in delivering tailored, personalized cancer medicine based on an individual's genetics.
› Verified 6 days ago
Jemin Amin, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 100 Parsonage Rd, Edison, NJ 08837 Phone: 732-207-9351 | |
Mrs. Rina Nijhawan, RPH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 95 Newfield Ave, Suite B, Edison, NJ 08837 Phone: 732-346-1333 Fax: 732-346-1999 | |
Ayah I Khattab, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 905 New Durham Rd, Edison, NJ 08817 Phone: 732-287-3652 | |
Mariesabel Marquez-zamuco, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 120 Fieldcrest Ave, Edison, NJ 08837 Phone: 732-346-2600 | |
Michael D Sheahan, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1199 Amboy Ave, Edison, NJ 08837 Phone: 732-494-0677 Fax: 732-452-0453 | |
Mr. Rajkumar Aerroju, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 289 Parsonage Rd, Edison, NJ 08837 Phone: 862-371-3372 |